Gene Query: TMEM59

Dataset Description Geneva Score
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 41.73
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 39.9
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 31.62
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 30.9
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 30.11
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 29.11
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 29.11
RNAseq of HEK293 cells after Chtop knockdown 26.57
Co-transcriptional loading of RNA export factors shapes the human transcriptome 26.57
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 24.69
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 22.32
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 22.14
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 21.66
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 21.17
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 21.17
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 21.0
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 20.43
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 20.34
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 19.62
Role of microRNAs in the interaction between Salmonella and the host cell 19.35
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 19.21
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 18.89
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 18.54
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 18.27
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 17.98
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 17.53
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 17.44
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 17.44
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 17.0
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 16.97
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 16.96
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 16.87
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 16.71
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 16.46
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 16.46
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 16.45
Effect of BMP inhibition or stimulation of primary human keratinocytes 16.38
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 16.38
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 16.34
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 16.34
Genome wide expression change in LCC2 and MCF-7 cells 16.32
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 15.97
Transcriptomic analysis of human tonsillar TFH subsets 15.89
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 15.57
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 15.48
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 15.46
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 15.43
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 15.36
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 15.21
An RNA-centric dissection of host complexes controlling flavivirus infection 15.21
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 15.08
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 14.8
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 14.73
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 14.72
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 14.61
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.53
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 14.52
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 14.33
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 14.18
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 14.17
The regulartory role of ZCCHC24 in splicing machinery 13.72
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 13.34
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 13.3
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 13.27
RNA-Seq with and without RNase treatment in PCa cell lines 13.27
NRDE2 negatively regulates nuclear exosome functions 13.21
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 13.14
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 13.1
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 13.09
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 13.09
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 13.09
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 13.01
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 12.92
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 12.88
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 12.85
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 12.84
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 12.67
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 12.63
Solid phase chemistry to covalently and reversibly capture thiolated RNA 12.29
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 12.29
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 12.25
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 12.12
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 12.11
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 12.11
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 12.01
Survival of pancreatic cancer cells lacking KRAS function 11.97
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 11.96
Ribosomal footprinting of CN34-Parental and CN34-LM1a 11.93
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 11.88
RNA-seq of MDA-MB-231 cells with TET1 knockout 11.82
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 11.73
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 11.59
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 11.54
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 11.45
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 11.41
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 11.38
Gene expression profiling of KSHV-infected periodontal ligament cells 11.37
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 11.35
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 11.26
Ribosomal footprinting of MDA-Parental and MDA-LM2 11.18
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 11.15
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 11.15
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 11.11
The comparison of high-throughput single-cell RNA-seq methods 11.06
CROP-Seq in Primary Human T Cells 11.02
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 11.02
Cerebellar differentiation in Ataxia-Telangiectasia 11.0
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 11.0
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 10.99
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 10.95
RNA-seq of shEZH2 cells 10.92
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 10.92
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 10.92
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 10.68
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 10.68
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 10.67
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 10.67
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 10.62
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 10.62
An optimization system for isolating and sequencing of single human colon cancer cells 10.53
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 10.47
A549 cells and MSR-A549 cells 10.41
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 10.41
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 10.31
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 10.14
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 10.13
High level DNA repair gene expression in human ES cells 10.07
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 10.03
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 10.01
Silencing SPIB in attached and floating state of H1703 lung cancer cells 10.0
Selective expression of long non-coding RNAs in a breast cancer cell progression model 9.98
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 9.98
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 9.92
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 9.87
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 9.87
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 9.76
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 9.76
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 9.76
Gene expression profile of human iPSC-derived nephron progenitor cells 9.74
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 9.73
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 9.7
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 9.69
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 9.69
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 9.67
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 9.67
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 9.65
Functional role of SLIT2 and ROBO1 in trophoblasts 9.62
Pharmacologic inhibition of STAT5 in AML 9.47
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 9.42
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 9.37
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 9.37
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 9.33
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 9.29
Chromatin-informed inference of transcriptional programs in gynecologic cancers 9.27
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 9.27
Global analysis of enhancer targets: Mosaic-seq 9.26
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 9.25
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 9.25
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.22
Transcriptome analysis of BAP1 knockout and restoration 9.18
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 9.18
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 9.17
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 9.17
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 9.16
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 9.16
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 9.15
Regulation of Lipids is Central to Replicative Senescence 9.12
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 9.12
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 9.11
Transcriptomic analysis of LSD1 9.08
Mapping interactions for the TNIP2 hub protein 9.06
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 9.04
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 9.04
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 9.03
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 9.02
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 8.98
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 8.98
Role for citron kinase in prostate cancer growth 8.98
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 8.97
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 8.9
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 8.9
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 8.84
ARID1A regulates condensin II distribution and chromosomal partition 8.84
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 8.84
SLAM-seq for K562 endogenous mRNA decay 8.8
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 8.75
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 8.74
Differential analysis of gene regulation at transcript resolution by RNA-Seq 8.74
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 8.73
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 8.73
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 8.68
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 8.68
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 8.68
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 8.64
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 8.63
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 8.63
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 8.63
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 8.5
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 8.5
3’ Uridylation Expands miRNA Target Repertoire 8.44
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 8.42
K562 polyA RNA-Seq 8.41
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 8.41
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 8.4
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 8.37
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 8.35
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 8.28
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 8.26
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 8.23
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 8.23
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 8.22
Transcriptomic analysis of ERR alpha orphan nuclear receptor 8.19
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 8.19
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 8.16
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 8.13
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 8.12
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 8.1
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 8.1
RNA-seq differential expression studies: more sequence, or more replication? 8.01
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 8.01
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 8.01
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 8.01
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 8.01
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 7.97
7.94
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 7.94
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 7.94
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 7.94
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 7.93
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 7.9
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 7.9
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 7.86
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 7.82
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 7.82
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 7.7
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 7.66
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 7.64
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 7.62
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 7.61
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 7.6
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 7.59
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 7.59
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 7.53
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 7.5
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 7.44
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 7.42
Transcription elongation regulates genome 3D structure 7.41
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.41
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.41
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 7.39
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 7.35
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 7.28
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 7.25
Cajal bodies are linked to genome conformation 7.23
Cajal bodies are linked to genome conformation [RNA-Seq] 7.23
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 7.22
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 7.21
Global transcriptome analysis of HAP1 cells 7.21
RNA-seq of RKO cells with cTAZ KO or putback 7.2
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 7.19
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.17
Gene expression profile of human placenta from T. Cruzi infected mothers 7.17
Identification of renal resident macrophages across species 7.13
mRNA expression profile of Lymphocytes 7.08
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 7.04
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 7.03
Real-time observation of light-controlled transcription in living cells 6.99
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 6.97
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.96
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.88
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.88
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.82
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.82
Overexpression and knockdown experiment for circCSNK1G3 6.81
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.77
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 6.77
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 6.71
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 6.68
Toxoplasma gondii infection of human retinal pigment epithelial cells 6.67
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 6.65
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 6.6
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 6.56
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 6.56
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 6.53
mRNA-Seq profiling of human developing kidney 6.51
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 6.48
Exploring the RNA landscape of endothelial exosomes 6.43
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 6.29
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.2
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 6.18
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 6.18
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 6.12
nELAVL HITS-CLIP in Alzheimer's Disease patients 6.01
Transcriptomic analysis of the HOTAIR-regulated genes 5.95
Biological effect of chronic mistranslation in mammalian cells 5.93
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 5.89
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 5.86
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 5.83
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 5.75
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 5.7
FBXW7 modulates stress response by post-translational modification of HSF1 5.69
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 5.69
Systematic discovery of endogenous human ribonucleoprotein complexes 5.67
Ribosomal protein RPL26 is the principal target of UFMylation 5.6
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.57
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 5.52
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 5.51
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 5.5
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 5.5
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.47
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 5.41
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 5.4
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 5.4
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.3
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 5.28
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.27
Human HAP1 cells before and after nutrient deprivation 5.27
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 5.23
Transcriptome sequencing of K-562 cells 5.22
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 5.22
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 5.2
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 5.2
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.19
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 5.1
Modeling Familial Cancer with iPSC Approaches 5.07
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 5.03
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 5.03
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 5.02
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 5.02
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 4.98
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 4.97
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 4.92
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 4.91
The age and genomic integrity of neurons after cortical stroke in humans 4.91
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 4.9
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 4.86
RNAseq in Alzheimer's Disease patients 4.86
A single-cell transcriptome atlas of the human pancreas 4.82
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 4.79
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 4.78
RNA-seq of cells with TET1 knockout 4.76
Determining mRNA half-lives on a transcriptome-wide scale 4.75
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 4.74
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 4.7
Identification of renal resident macrophages across species [C1] 4.69
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 4.69
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 4.64
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 4.6
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 4.6
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.6
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 4.59
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.58
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.58
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 4.58
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.55
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.54
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 4.39
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.32
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 4.24
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 4.2
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 4.2
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 4.16
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 4.13
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 4.13
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 4.07
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.04
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.91
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 3.85
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 3.84
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 3.79
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.7
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.65
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 3.64
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 3.64
Induced DNA demethylation, genome instability and transcription 3.64
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 3.62
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.61
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 3.59
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.54
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 3.53
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 3.53
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.52
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.52
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.5
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 3.49
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.49
Tracing Enhancer Networks using Epigenetic Traits (TENET) 3.47
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 3.46
Characterization of the Merkel cell carcinoma miRNome 3.45
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 3.45
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 3.44
RNA Sequencing of Human iPS derived Cardiomyocytes 3.36
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 3.36
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 3.2
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 3.2
Transcriptome analysis of peripheral blood monocytes 3.16
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.11
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 3.11
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 3.07
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.03
mRNA expression in human DAOY cells 2.99
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 2.88
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.85
Aging-associated patterns in the expression of human endogenous retroviruses 2.84
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 2.74
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.74
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 2.73
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.7
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.62
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.62
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 2.6
Induction of Cardiomyocyte Proliferation [pz-822_human] 2.6
Enhancer activation during EGF response 2.52
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.52
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.47
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.42
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.39
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.37
O-glcnAc reprograms cellular energetics 2.31
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.25
Dilated cardiomyopathy vs Myocarditis 2.23
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.23
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.19
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 2.16
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 2.05
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.04
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.04
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.03
RNA-Seq from human ILC transitional populations 2.02
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.02
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 1.99
RNA-Seq of PRMT1 overexpression ECA109 cells 1.96
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.96
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.92
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.9
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.85
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.82
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.76
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.69
6mer seed toxicity in viral microRNAs 1.68
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.56
mRNA recovered upon RNF219 IP. [RNA-IP] 1.55
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.47
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.47
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 1.39
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.38
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.37
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.36
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.34
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.33
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.26
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 1.2
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.16
Iron response of HepG2 cells 1.13
Metabolism as an early predictor of DPSCs aging 1.12
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.09
RNA-seq data 1.03
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.99
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.97
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.97
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.93
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.91
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.83
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.82
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.81
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.71
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.67
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.66
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.66
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.65
Ribosome profiling upon inhibition of eIF4A 0.64
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.62
Differential gene expression profiles in imatinib-resistant cell lines 0.48
Human Tfh cell RNA bulk sequencing 0.48
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.43
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.43
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.43
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.43
Oncogenic roles of ARID5B in T-ALL 0.43
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.41
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.38
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.36
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.33
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.29
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.26
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.25
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.25
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.25
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.24
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.22
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.19
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.18
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.17
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.15
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.14
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.09
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.06
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.06
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.03
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation